CompletedPhase 3NCT00755781

Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation

Studying Bronchiolitis obliterans

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
APT Pharmaceuticals, Inc.
Principal Investigator
Stephen Dilly, MD PhD
APT Pharmaceuticals, Inc.
Intervention
Cyclosporine Inhalation Solution (CIS)(drug)
Enrollment
284 enrolled
Eligibility
18 years · All sexes
Timeline
20082011

Study locations (19)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00755781 on ClinicalTrials.gov

Other trials for Bronchiolitis obliterans

Additional recruiting or active studies for the same condition.

See all trials for Bronchiolitis obliterans

← Back to all trials